Adapting Project UPLIFT for Hispanic Patients With Epilepsy II

May 19, 2020 updated by: NYU Langone Health

Adapting Project UPLIFT (Using Practice and Learning to Increase Favorable Thoughts) is for Hispanic Patients With Epilepsy II

The purpose of this study is to adapt Project UPLIFT for Hispanic adults with epilepsy and depression. Project UPLIFT (Using Practice and Learning to Increase Favorable Thoughts) is a home-based intervention that teaches cognitive and mindfulness skills to people with epilepsy by phone to reduce their depression and improve quality of life (QOL); it was developed at Emory University with CDC funding. The purpose of this study is to adapt Project UPLIFT for Hispanic adults with epilepsy and depression. Project UPLIFT (Using Practice and Learning to Increase Favorable Thoughts) is a home-based intervention that teaches cognitive and mindfulness skills to people with epilepsy by phone to reduce their depression and improve quality of life (QOL); it was developed at Emory University with CDC funding.

Study Overview

Detailed Description

The goal of this study is to adapt Project UPLIFT for Hispanic adults with epilepsy and depression. A 2-arm randomized control trial will be conducted to evaluate the feasibility, acceptability and effects of Project UPLIFT versus usual care (UC) in Hispanic patients with epilepsy.

The specific aim of this study is: To evaluate the feasibility, acceptability and short- and long-term effects of the adapted intervention on depression and other outcomes in 72 English- and Spanish-speaking Hispanic epilepsy patients.

Study Type

Interventional

Enrollment (Actual)

72

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • New York
      • New York, New York, United States, 10016
        • New York University School of Medicine

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

21 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • self-identified as Hispanic
  • English or Spanish speaking
  • diagnosis of epilepsy for at least one year post diagnosis
  • willing to participate in 8 one-hour telephone sessions every week for eight weeks.
  • willing to be audio-taped
  • Elevated depressive symptoms (Center for Epidemiological Studies Depression Scale (CES-D) score >13

Exclusion Criteria:

  • Severe depression (CES-D > 37)
  • Active suicidal ideation
  • Significant cognitive impairment (evident during screening)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: UPLIFT
Project UPLIFT (Using Practice and Learning to Increase Favorable Thoughts) is a home-based intervention that teaches cognitive and mindfulness skills to people with epilepsy by phone to reduce their depression and improve quality of life (QOL).

Description of the UPLIFT program: Participants who choose to participate in UPLIFT will complete 8 weekly group sessions via telephone.

Session 1: Introduction to UPLIFT/Noticing Thoughts Session 2: Checking and Changing Thoughts Session 3: Coping & Relaxing Session 4: Attention & Mindfulness Session 5: The Present as a Calm Place Session 6: Thoughts as Changeable, Thoughts as Not Fixed Session 7: Focus on Pleasure & the Importance of Reinforcement Session 8: Preventing Lapses and Giving Thanks

Active Comparator: USUAL CARE
Participants randomized to the UC group will receive printed educational materials on management of epilepsy in English or Spanish as preferred.
Participants randomized to the UC group will receive printed educational materials on management of epilepsy in English or Spanish as preferred.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Patient Health Questionnaire (PHQ-9)
Time Frame: 12 Months
This measure assesses depressive symptoms in the past two weeks based on DSM-IV diagnostic criteria for major depression.
12 Months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Quality Of Life in Epilepsy (QOLIE-10)
Time Frame: 12 Months
This measure assesses health-related quality of life for adults with epilepsy.
12 Months
PROMIS-Global
Time Frame: 12 Months
This 10-item measure was developed by NIH to assess physical, mental and social functioning. It is a generic rather than disease-specific measure of global health.
12 Months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Work Productivity and Activity Impairment Questionnaire (WPAI)
Time Frame: 12 Months
This self-report measure assesses the impact of disease on productivity and work productivity loss due to general health or a specified health problem.
12 Months
Self-Compassion Scale (SCS)
Time Frame: 12 Months
This measure assesses trait levels of self-compassion, including the thoughts, emotions and behaviors associated with the various components of self-compassion.
12 Months
Satisfaction with Life Scale (SWLS)
Time Frame: 12 Months
This 5-item instrument measures global cognitive judgments of satisfaction with one's life.
12 Months
Interpersonal Support Evaluation List (ISEL)
Time Frame: 12 Months
This measure assesses the perceived availability of appraisal, belonging and tangible social support.
12 Months
Five Facet Mindfulness Questionnaire Description (FFMQ) Short form
Time Frame: 12 Months
This 24-item measure assesses the construct of mindfulness through five component skills: observing, describing, acting with awareness, non-judging of inner experience, and non-reactivity to inner experience.
12 Months
Ruminative Responses Scale (RRS)
Time Frame: 12 Months
This 22-item scale assesses cognitive responses to depressed mood.
12 Months
Perceived Stress Scale (PSS-10)
Time Frame: 12 Months
This 10-item measure assesses the degree to which situations in one's life are appraised as stressful or overwhelming.
12 Months
Pittsburgh Sleep Quality Index (PSQI)
Time Frame: 12 Months
This 19-item questionnaire assesses sleep quality over the past month.
12 Months
Epilepsy Stigma Scale
Time Frame: 12 Months
This 10-item measure assesses the degree to which a person believes that epilepsy is perceived as negative and interferes with relationships with others.
12 Months
Healthcare Utilization
Time Frame: 12 Months
This self-report questionnaire assesses the use of healthcare services (e.g., clinic visits ED visits, etc).
12 Months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Tanya Spruill, NYU Langone Health

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2016

Primary Completion (Actual)

September 1, 2019

Study Completion (Actual)

September 1, 2019

Study Registration Dates

First Submitted

December 20, 2016

First Submitted That Met QC Criteria

December 20, 2016

First Posted (Estimate)

December 22, 2016

Study Record Updates

Last Update Posted (Actual)

May 21, 2020

Last Update Submitted That Met QC Criteria

May 19, 2020

Last Verified

May 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • 16-01531

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Epilepsy

Clinical Trials on Using Practice and Learning to Increase Favorable Thoughts

Subscribe